Buzzard Pharmaceutical
Phase 2Buzzard Pharmaceuticals, a clinical-stage biotech company developing innovative IL-1 targeted therapies focused on inflammation-driven diseases.
Founded
2018
Focus
Small Molecules
About
Buzzard Pharmaceuticals, a clinical-stage biotech company developing innovative IL-1 targeted therapies focused on inflammation-driven diseases.
Company Info
TypePrivate
Founded2018
LocationStockholm, Sweden
StagePhase 2
Contact
SIMILAR COMPANIES
Basic Genomics
Pre-clinical · Stockholm
2A Pharma
Phase 1 · Stockholm
Abliva
Pre-clinical · Lund
Affibody
Phase 1 · Solna
Alligator Bioscience
Phase 1 · Lund
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile